Advaxis Inc – ADXS
Advaxis Inc. is a biotechnology company having developments in immunotherapies with at aim at enlisting the immunity of the body to fight against cancer. The market cap of the company is $88.04 M and the 52-week low-high price is $1.51- $8.36. This American company has headquarters in Princeton, NJ, United States. It is devoted to the usage of Listeria monocytogenes (Lm) for innovation, progression, and marketing of immunotherapies for cancer treatment.
The platform on which the company manufactures its products is attenuated LM having an ability to secrete adjuvant fusion/antigen proteins to make an impact on … Read More